JESSICA PARENT: Open Payments
NPI 1497531792 · SOMERSWORTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 41 payments from 14 companies in 2025. Trend: 2023 $48 · 2024 $357 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $284 |
| Gilead Sciences, Inc. | 5 | $109 |
| Baxter Healthcare | 1 | $61 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Indivior Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: VRAYLAR, Hillrom - Carnation Ambulatory Monitor, MAVYRET, FANAPT, APTIMA, SUBLOCADE, CAPVAXIVE, MOUNJARO.
Industry payments across NH — which companies pay providers there.
